Y.-T. He et al. / Tetrahedron Letters 46 (2005) 5393–5397
5397
13. A recent review for applications of Sonogashira reactions,
see: Dai, W.-M. Curr. Med. Chem. 2003, 10, 2265.
14. Morpain, C.; Tisserand, M. J. Chem. Soc., Perkin Trans. 1
1979, 1379.
Science and Technology (04DZ14901). We thank Dr.
Terrence R. Burke at NCI for helpful commentson
manuscript preparation.
15. Gawronska, K. Carbohydr. Res. 1988, 176, 79.
16. Yadav, J. S.; Chander, M. C.; Joshi, B. V. Tetrahedron
Lett. 1988, 29, 2737.
References and notes
17. (a) Compound 18 wasconverted into the enantiomer of
(3S,4S)-3,4-bis(benzyloxy)hexa-1,5-diyne, which was pre-
pared by the known transformations from L-tartaric
acid.17b The optical rotationsof both enantiomersare
matched each other.(b) Mukai, C.; Kasamatsu, E.; Oh-
yama, T.; Hanaoka, M. J. Chem. Soc., Perkin Trans. 1
2000, 737.
1. Recent reviews, see: (a) Johnson, H. A.; Oberlies, N. H.;
Alami, F. Q.; McLaughlin, J. L. Bioact. Nat. Prod. 2000,
173; (b) Alali, F. Q.; Liu, X.-X.; Mclaughlin, J. L. J. Nat.
Prod. 1999, 62, 504.
2. Mashall, J. A.; Jiang, H. J. Org. Chem. 1998, 63, 7066.
3. Ye, Q.; He, K.; Oberlies, N. H.; Zeng, L.; Shi, G.; Evert,
D.; Mclaughlin, J. L. J. Med. Chem. 1996, 39, 1790.
4. (a) Yao, Z.-J.; Wu, Y.-L. Tetrahedron Lett. 1994, 35, 157;
(b) Yao, Z.-J.; Wu, Y.-L. J. Org. Chem. 1995, 60, 1170; (c)
Yu, Q.; Wu, Y.; Ding, H.; Wu, Y.-L. J. Chem. Soc.,
Perkin Trans. 1 1999, 9, 1183; (d) Yu, Q.; Yao, Z.-J.;
Chen, X.-G.; Wu, Y.-L. J. Org. Chem. 1999, 64, 2440; (e)
Hu, T.-S.; Yu, Q.; Lin, Q.; Wu, Y.-L.; Wu, Y. Org. Lett.
1999, 1, 399; (f) Yu, Q.; Wu, Y.-K.; Xia, L.-J.; Tang,
M.-H.; Wu, Y.-L. Chem. Commun. 1999, 2, 129; (g) Hu,
T.-S.; Wu, Y.-L.; Wu, Y. Org. Lett. 2000, 2, 887; (h) Hu,
T.-S.; Yu, Q.; Wu, Y.-L.; Wu, Y. J. Org. Chem. 2001, 66,
853.
OBn
OH
BnBr, NaH, THF
92%
[α]D -135.6
[α]D +134.8
OBn
OBn
OH
18
HO
OH
HOOC
COOH
OBn
5. A review for acetogenin synthesis, see: Cassiraghi, G.;
Zanardi, F.; Battistini, L.; Rassu, G.; Appendino, G.
Chemtracts: Org. Chem. 1998, 11, 803, and referencescited
therein.
L-tartaric acid
18. Polt, R.; Sames, D.; Chruma, J. J. Org. Chem. 1999, 64,
6147.
19. Maezaki, N.; Kojima, N.; Asia, N.; Tominaga, H.;
Tanaka, T. Org. Lett. 2002, 4, 2977.
6. For total syntheses of acetogenins after 1998, see: Natt-
´
rass, G. L.; Dıez, E.; Mclachlan, M. M.; Dixon, D. J.; Ley,
S. V. Angew. Chem., Int. Ed. 2005, 44, 580, and Refs. 3–9
cited therein.
20. Tokunaga, M.; Larrow, J. F.; Jacobsen, E. N. Science
1997, 277, 936.
21. Yamaguchi, M.; Hirao, I. Tetrahedron Lett. 1983, 24, 391.
7. (a) Motoyama, T.; Yabunaka, H.; Miyoshi, H. Bioorg.
Med. Chem. Lett. 2002, 12, 2089; (b) Hoye, T. R.; Ye, Z.
J. Am. Chem. Soc. 1996, 118, 1801.
8. (a) Jiang, S.; Liu, Z.-H.; Sheng, G.; Zeng, B.-B.; Cheng,
X.-G.; Wu, Y.-L.; Yao, Z.-J. J. Org. Chem. 2002, 67, 3404;
(b) Liu, H.-X.; Yao, Z.-J. Tetrahedron Lett. 2005, 46,
3525.
9. Kolk, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B.
Chem. Rev. 1994, 94, 2509.
10. A review for synthesis of oligo-THFs by intramolecular
Williamson reaction, see: Koert, U. Synthesis 1995, 115.
11. Yoda, H.; Nakaseko, Y.; Takabe, K. Synlett 2002, 9,
1532, and referencescited therein.
22. Data for synthetic 1: [a]D 11.3 (c 0.13, EtOH); lit. 3 [a]D 14
1
(c 0.10, EtOH). H NMR (300 MHz, CDCl3): d 7.19 (q,
J = 1.8 Hz, 1H), 5.06 (qq, J = 6.9, 1.5 Hz, 1H), 3.86–3.88
(m, 1H), 3.81–3.86 (m, 4H), 3.37–3.41 (m, 2H), 2.52–2.54
(m, 1H), 2.40 (dd, J = 15.1, 8.1 Hz, 1H), 1.97–2.00 (m,
4H), 1.53–1.70 (m, 4H), 1.20–1.50 (m, 34H), 1.43 (d,
J = 6.5 Hz, 3H), 0.88 (t, J = 6.9 Hz, 3H) ppm. 13C NMR
(75 MHz, CDCl3): d 174.56, 151.77, 131.16, 83.16, 83.00,
81.78, 81.73, 77.93, 74.09, 73.82, 69.76, 37.20, 33.42, 33.37,
31.89, 29.70, 29.65, 29.62, 29.60, 29.58, 29.32, 28.92, 28.36,
28.33, 25.62, 22.65, 19.07, 14.01 ppm. HRMS (ESI, m/z)
calcd for (C35H62O7+Na)+: 617.4388. Found: 617.4375.
12. Vares, L.; Rein, T. J. Org. Chem. 2002, 67, 7226, and
referencescited therein.